The Short-Term Efficacy of Bifidobacterium Quadruple Viable Tablet in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: Potentially Mediated by Metabolism Rather Than Diversity Regulation

The record

Year: 2022
Journal: The American Journal of Gastroenterology
Pages: 1256 - 1267
Authors: T. Bai, Zhiyue Xu, Peijun Xia, Yichao Feng, Bing Liu, Hong-liang Liu, Yunwang Chen, Guangjun Yan, Bin Lv, Zaihong Yan, N. Dai, Y. Long, Wei Wei, Zhihong Shi, Xiaoqing Li, X. Fang, Huibin Gao, Lingzhi Qi, X. Hou
DOI: 10.14309/ajg.0000000000002147

Source bibliography; study design, findings and full text have not been independently reviewed.